EMT 100
Alternative Names: [PET]EMI-100; [PET]EMI-100-001; [TH]EMT-100; [TH]EMT-100-001; EMI-100; EMT-100Latest Information Update: 28 Feb 2024
At a glance
- Originator Edinburgh Molecular Imaging
- Class Antineoplastics; Imaging agents; Peptides; Radiopharmaceutical diagnostics; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters; Positron-emission tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Feb 2024 No recent reports of development identified for preclinical development in Cancer in United Kingdom
- 28 Feb 2024 No recent reports of development identified for preclinical development in Cancer(Diagnosis) in United Kingdom
- 30 Jan 2020 Preclinical trials in Cancer (Diagnosis) in United Kingdom (unspecified route) (Edinburgh Molecular Imaging pipeline, January 2020)